ICRF was established to harness Israel’s educational and scientific resources in the fight against all cancers. The bulk of the work that ICRF supports is in basic research; that is, research to uncover the molecular biological events that lead to cancer in order to prevent or reverse the process. Virtually every drug, therapy and diagnostic test that is used in the clinic today originated from basic research. We cannot cure cancer if we don’t understand what causes it; and although basic, fundamental research may not result in an immediate cure, expanding our knowledge of the underlying processes is what will eventually lead to that “eureka” moment.

The areas of cancer research directly supported by ICRF include:

Anticancer Vaccines
Bone Marrow Transplantation
Brain Tumors
Breast Cancer
Cancer Stem Cells and Cellular Reprogramming
Childhood Malignancies
Colorectal Cancer
Development of Novel Drugs, such as Gleevec and Velcade
Endometrial Cancer
Eye Cancer
Gastrointestinal Cancer
Genetic Mutation and Repair
Head and Neck Cancers
Immunology and Immunotherapy
Inflammation and Cancer
Kidney Cancer

Leukemia and Lymphoma
Lung Cancer
Gut Microbiome and the Tumor Microenvironment
Oral Cancer
Ovarian Cancer
Pain Management and Quality of Life Issues
Pancreatic Cancer
Programmed Cell Death (Apoptosis)
Prostate Cancer
Radiation Therapy and the DNA Damage Response
Skin Cancer
Targeted Therapy
Tumor Blood Vessel Growth (Angiogenesis)
Tumor Metastases
Tumor Suppressor Genes, such as p53
Tumor Viruses


2019-2020 Research Grant Recipients

For the 2019-2020 funding year, ICRF is supporting 72 grants to leading investigators at institutions across Israel:

9 Jacki and Bruce Barron Cancer Research Scholars’ Program Grants (A Partnership between ICRF and City of Hope)
3 Immunotherapy Promise Grants (A Partnership between ICRF and Cancer Research Institute)
1 International Collaboration Grant
1 Barbara S. Goodman Endowed RCDA for Pancreatic Cancer
2 Brause Family Initiative for Quality of Life Grants
11 Research Career Development Awards (RCDAs)
4 Len & Susan Mark Initiative for Ovarian and Uterine/MMMT Cancers Grants
17 Project Grants
7 Acceleration Grants
12 Research Professorship Grants  
5 Postdoctoral Fellowships

Among the areas of cancer research directly sponsored by ICRF in 2019-2020 are studies in: blood, brain, breast, colorectal, endometrial, gastrointestinal, head and neck, kidney, lung, oral, ovarian and uterine, pancreatic, pediatric, and skin cancers; anticancer drug mechanisms and design, drug resistance, and targeted therapy; pain management and quality of life issues; tumor blood vessel growth (angiogenesis); cancer stem cells and cellular reprogramming; expression, regulation, mutation and repair of genes and the DNA damage response; tumor metastasis; inflammation and cancer; immunology and immunotherapy; protein structures and protein interactions; cell signaling and cell-cycle regulation; the gut microbiome; and the tumor microenvironment.


Meet Our Grantees:

ICRF Research Grants Database

Explore our database of current grant recipients

ICRF Grants Awarded By Year

View or download an ICRF research grant awards table from the 2004-2005 funding cycle to the present:

“ICRF support of my research was extremely important in the development of Doxil®, a highly effective form of targeted chemotherapy.”

Alberto Gabizon, MD, PhD, Shaare Zedek Medical Center

“When I look back and think to whom I should be grateful, there is no doubt that I should thank ICRF.”

Varda Rotter, PhD, Weizmann Institute, Pioneer in the Discovery of the p53 Tumor Suppressor Gene

“I am extremely grateful to ICRF. The funding was crucial for us to advance our science on cancer.”

Naama Geva-Zatorsky, PhD, Technion-Israel Institute of Technology, ICRF Acceleration Grant Recipient

“I would like to thank ICRF and its donors for supporting our research and for progressing cancer research in Israel.”

Ziv Gil, MD, PhD, Rambam Heath Care Campus, ICRF-COH Jacki & Bruce Barron Cancer Research Scholars’ Program Grant Recipient